SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001798749-23-000021
Filing Date
2023-04-05
Accepted
2023-04-05 16:30:14
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 tmb-20220815x424b5.htm 424B5 407489
2 GRAPHIC tmb-20220815x424b5001.jpg GRAPHIC 11976
3 GRAPHIC tmb-20220815x424b5002.jpg GRAPHIC 12026
4 GRAPHIC tmb-20220815x424b5003.jpg GRAPHIC 14757
  Complete submission text file 0001798749-23-000021.txt   462342
Mailing Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451
Business Address 930 WINTER STREET SUITE M-500 WALTHAM MA 02451 617-443-2400
Aerovate Therapeutics, Inc. (Filer) CIK: 0001798749 (see all company filings)

IRS No.: 831377888 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-266883 | Film No.: 23802946
SIC: 2834 Pharmaceutical Preparations